• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡咯里西啶生物碱诱导的肝毒性与活性代谢物衍生的吡咯蛋白加合物的形成有关。

Pyrrolizidine Alkaloid-Induced Hepatotoxicity Associated with the Formation of Reactive Metabolite-Derived Pyrrole-Protein Adducts.

机构信息

School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong 4054577, China.

School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510000, China.

出版信息

Toxins (Basel). 2021 Oct 13;13(10):723. doi: 10.3390/toxins13100723.

DOI:10.3390/toxins13100723
PMID:34679016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8540779/
Abstract

Pyrrolizidine alkaloids (PAs) with 1,2-unsaturated necine base are hepatotoxic phytotoxins. Acute PA intoxication is initiated by the formation of adducts between PA-derived reactive pyrrolic metabolites with cellular proteins. The present study aimed to investigate the correlation between the formation of hepatic pyrrole-protein adducts and occurrence of PA-induced liver injury (PA-ILI), and to further explore the use of such adducts for rapidly screening the hepatotoxic potency of natural products which contain PAs. Aqueous extracts of (containing one PA: monocrotaline) and (containing two PAs: senecionine and seneciphylline) were orally administered to rats at different doses for 24 h to investigate PA-ILI. Serum alanine aminotransferase (ALT) activity, hepatic glutathione (GSH) level, and liver histological changes of the treated rats were evaluated to assess the severity of PA-ILI. The levels of pyrrole-protein adducts formed in the rats' livers were determined by a well-established spectrophotometric method. The biological and histological results showed a dose-dependent hepatotoxicity with significantly different toxic severity among groups of rats treated with herbal extracts containing different PAs. Both serum ALT activity and the amount of hepatic pyrrole-protein adducts increased in a dose-dependent manner. Moreover, the elevation of ALT activity correlated well with the formation of hepatic pyrrole-protein adducts, regardless of the structures of different PAs. The findings revealed that the formation of hepatic pyrrole-protein adducts-which directly correlated with the elevation of serum ALT activity-was a common insult leading to PA-ILI, suggesting a potential for using pyrrole-protein adducts to screen hepatotoxicity and rank PA-containing natural products, which generally contain multiple PAs with different structures.

摘要

吡咯里西啶生物碱(PAs)具有 1,2-不饱和的 necine 碱基,是具有肝毒性的植物毒素。急性 PA 中毒是由 PA 衍生的反应性吡咯代谢物与细胞蛋白之间形成加合物引起的。本研究旨在探讨肝吡咯蛋白加合物的形成与 PA 诱导的肝损伤(PA-ILI)之间的相关性,并进一步探索利用这些加合物快速筛选含有 PA 的天然产物的肝毒性。将 (含有 1 种 PA:野百合碱)和 (含有 2 种 PAs:山梗菜碱和山梗菜菲林)的水提取物以不同剂量口服给予大鼠 24 h,以研究 PA-ILI。通过评估血清丙氨酸氨基转移酶(ALT)活性、肝谷胱甘肽(GSH)水平和处理大鼠的肝组织学变化来评估 PA-ILI 的严重程度。通过建立良好的分光光度法测定大鼠肝脏中形成的吡咯蛋白加合物的水平。生物和组织学结果显示,含不同 PA 的草药提取物处理的大鼠表现出剂量依赖性肝毒性,各组之间的毒性严重程度有显著差异。血清 ALT 活性和肝吡咯蛋白加合物的量均呈剂量依赖性增加。此外,ALT 活性的升高与肝吡咯蛋白加合物的形成密切相关,而与不同 PA 的结构无关。这些发现表明,肝吡咯蛋白加合物的形成与血清 ALT 活性的升高直接相关,这是导致 PA-ILI 的共同损伤,表明使用吡咯蛋白加合物筛选肝毒性和对含有 PA 的天然产物进行排序具有潜力,因为这些天然产物通常含有结构不同的多种 PA。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/8540779/446f218b8d90/toxins-13-00723-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/8540779/2e415edd2624/toxins-13-00723-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/8540779/a21c880a4371/toxins-13-00723-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/8540779/202623d447fd/toxins-13-00723-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/8540779/a44d17d83c08/toxins-13-00723-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/8540779/446f218b8d90/toxins-13-00723-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/8540779/2e415edd2624/toxins-13-00723-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/8540779/a21c880a4371/toxins-13-00723-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/8540779/202623d447fd/toxins-13-00723-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/8540779/a44d17d83c08/toxins-13-00723-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b8/8540779/446f218b8d90/toxins-13-00723-g005.jpg

相似文献

1
Pyrrolizidine Alkaloid-Induced Hepatotoxicity Associated with the Formation of Reactive Metabolite-Derived Pyrrole-Protein Adducts.吡咯里西啶生物碱诱导的肝毒性与活性代谢物衍生的吡咯蛋白加合物的形成有关。
Toxins (Basel). 2021 Oct 13;13(10):723. doi: 10.3390/toxins13100723.
2
Pyrrole-protein adducts - A biomarker of pyrrolizidine alkaloid-induced hepatotoxicity.吡咯蛋白加合物——吡咯里西啶生物碱诱导肝毒性的生物标志物。
J Food Drug Anal. 2018 Jul;26(3):965-972. doi: 10.1016/j.jfda.2018.05.005. Epub 2018 Jun 14.
3
The role of formation of pyrrole-ATP synthase subunit beta adduct in pyrrolizidine alkaloid-induced hepatotoxicity.吡咯烷-ATP 合酶亚基β加合物形成在吡咯里西啶生物碱诱导的肝毒性中的作用。
Arch Toxicol. 2018 Nov;92(11):3403-3414. doi: 10.1007/s00204-018-2309-6. Epub 2018 Sep 22.
4
Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity.吡咯里西啶生物碱对人肝实质细胞和肝窦内皮细胞的细胞毒性:活性代谢产物介导吡咯里西啶生物碱诱导肝毒性的确凿证据。
Chem Biol Interact. 2016 Jan 5;243:119-26. doi: 10.1016/j.cbi.2015.09.011. Epub 2015 Sep 10.
5
Developing urinary pyrrole-amino acid adducts as non-invasive biomarkers for identifying pyrrolizidine alkaloids-induced liver injury in human.开发尿吡咯烷酸-氨基酸加合物作为非侵入性生物标志物,用于鉴定吡咯里西啶生物碱诱导的肝损伤。
Arch Toxicol. 2021 Oct;95(10):3191-3204. doi: 10.1007/s00204-021-03129-6. Epub 2021 Aug 14.
6
First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans.首例吡咯里西啶生物碱 N-氧化物诱导的肝窦阻塞综合征的人类证据。
Arch Toxicol. 2017 Dec;91(12):3913-3925. doi: 10.1007/s00204-017-2013-y. Epub 2017 Jun 15.
7
Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.与食用菊三七相关的肝窦阻塞综合征。
J Hepatol. 2011 Apr;54(4):666-73. doi: 10.1016/j.jhep.2010.07.031. Epub 2010 Sep 22.
8
The long persistence of pyrrolizidine alkaloid-derived pyrrole-protein adducts in vivo: Kinetic study following multiple exposures of a pyrrolizidine alkaloid containing extract of Gynura japonica.体内吡咯里西啶生物碱衍生的吡咯蛋白加合物的长期持久性:含有菊三七提取物的吡咯里西啶生物碱多次暴露后的动力学研究。
Toxicol Lett. 2020 May 1;323:41-47. doi: 10.1016/j.toxlet.2020.01.021. Epub 2020 Jan 23.
9
Fasting augments pyrrolizidine alkaloid-induced hepatotoxicity.禁食会增强吡咯里西啶生物碱诱导的肝毒性。
Arch Toxicol. 2022 Feb;96(2):639-651. doi: 10.1007/s00204-021-03193-y. Epub 2021 Nov 18.
10
Pulmonary toxicity is a common phenomenon of toxic pyrrolizidine alkaloids.肺毒性是毒吡咯里西啶生物碱的常见现象。
J Environ Sci Health C Toxicol Carcinog. 2020;38(2):124-140. doi: 10.1080/26896583.2020.1743608. Epub 2020 Apr 27.

引用本文的文献

1
Underlying mechanisms and treatment of acetaminophen‑induced liver injury (Review).对乙酰氨基酚诱导的肝损伤的潜在机制与治疗(综述)
Mol Med Rep. 2025 Apr;31(4). doi: 10.3892/mmr.2025.13471. Epub 2025 Feb 28.
2
In vitro-in silico study on the influence of dose, fraction bioactivated and endpoint used on the relative potency value of pyrrolizidine alkaloid N-oxides compared to parent pyrrolizidine alkaloids.关于剂量、生物活化分数和所使用的终点对吡咯里西啶生物碱氮氧化物相对于母体吡咯里西啶生物碱的相对效价的影响的体外-计算机模拟研究。
Curr Res Toxicol. 2024 Mar 1;6:100160. doi: 10.1016/j.crtox.2024.100160. eCollection 2024.
3

本文引用的文献

1
Metabolic Toxification of 1,2-Unsaturated Pyrrolizidine Alkaloids Causes Human Hepatic Sinusoidal Obstruction Syndrome: The Update.1,2-不饱和吡咯里西啶生物碱的代谢解毒导致人类肝窦阻塞综合征:最新进展。
Int J Mol Sci. 2021 Sep 27;22(19):10419. doi: 10.3390/ijms221910419.
2
Developing urinary pyrrole-amino acid adducts as non-invasive biomarkers for identifying pyrrolizidine alkaloids-induced liver injury in human.开发尿吡咯烷酸-氨基酸加合物作为非侵入性生物标志物,用于鉴定吡咯里西啶生物碱诱导的肝损伤。
Arch Toxicol. 2021 Oct;95(10):3191-3204. doi: 10.1007/s00204-021-03129-6. Epub 2021 Aug 14.
3
Metabolism-mediated cytotoxicity and genotoxicity of pyrrolizidine alkaloids.
INTEDE 2.0: the metabolic roadmap of drugs.
INTEDE 2.0:药物的代谢途径图。
Nucleic Acids Res. 2024 Jan 5;52(D1):D1355-D1364. doi: 10.1093/nar/gkad1013.
4
Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations.药物在人类肝脏中的分子特异性毒理学与动物比较:基本考虑因素。
Int J Mol Sci. 2023 Apr 3;24(7):6663. doi: 10.3390/ijms24076663.
吡咯里西啶生物碱的代谢介导的细胞毒性和遗传毒性。
Arch Toxicol. 2021 Jun;95(6):1917-1942. doi: 10.1007/s00204-021-03060-w. Epub 2021 May 18.
4
Authentication of Saposhnikovia divaricata (Trucz.) Schischk and its two adulterants based on their macroscopic morphology and microscopic characteristics.基于宏观形态和微观特征鉴定独活及其两种混淆品。
Microsc Res Tech. 2021 May;84(5):1089-1094. doi: 10.1002/jemt.23651. Epub 2020 Nov 20.
5
Clinical application of pyrrole-hemoglobin adducts as a biomarker of pyrrolizidine alkaloid exposure in humans.吡咯烷-血红蛋白加合物在人体吡咯里西啶生物碱暴露生物标志物中的临床应用。
Arch Toxicol. 2021 Feb;95(2):759-765. doi: 10.1007/s00204-020-02947-4. Epub 2020 Nov 18.
6
Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China.土木香(旋覆花):中国吡咯里西啶生物碱肝损伤的罪魁祸首。
Acta Pharmacol Sin. 2021 Aug;42(8):1212-1222. doi: 10.1038/s41401-020-00553-9. Epub 2020 Nov 5.
7
Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis.1993年至2020年年中发表的81856例特异质性药物性肝损伤和14029例药物超敏反应性肝损伤病例中RUCAM在因果关系评估中的全球应用:一项综合分析
Medicines (Basel). 2020 Sep 29;7(10):62. doi: 10.3390/medicines7100062.
8
Pyrrolizidine alkaloids in food and phytomedicine: Occurrence, exposure, toxicity, mechanisms, and risk assessment - A review.食品和植物药中的吡咯里西啶生物碱:发生、暴露、毒性、机制和风险评估-综述。
Food Chem Toxicol. 2020 Feb;136:111107. doi: 10.1016/j.fct.2019.111107. Epub 2020 Jan 3.
9
The pyrrolizidine alkaloid senecionine induces CYP-dependent destruction of sinusoidal endothelial cells and cholestasis in mice.吡咯里西啶生物碱千里光碱诱导小鼠肝窦内皮细胞细胞色素依赖破坏和胆汁淤积。
Arch Toxicol. 2020 Jan;94(1):219-229. doi: 10.1007/s00204-019-02582-8. Epub 2019 Oct 12.
10
Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes.吡咯里西啶生物碱诱导的肝窦阻塞综合征:发病机制、临床表现、诊断、治疗和结局。
World J Gastroenterol. 2019 Jul 28;25(28):3753-3763. doi: 10.3748/wjg.v25.i28.3753.